APA (7th ed.) Citation

Karput, I. A., Snezhitsky, V. A., Kurbat, M. N., Gorustovich, O. A., Kopytsky, A. V., & Babenko, A. S. Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Karput, I. A., V. A. Snezhitsky, M. N. Kurbat, O. A. Gorustovich, A. V. Kopytsky, and A. S. Babenko. Molecular Genetic Indicators of the Probability of Early Myocardial Systolic Dysfunction Signs in Doxorubicin Chemotherapy in Patients with Breast Cancer of Moderate and Low HFA-ICOS Risk Groups. «FIRMA «SILICEA» LLC.

MLA (9th ed.) Citation

Karput, I. A., et al. Molecular Genetic Indicators of the Probability of Early Myocardial Systolic Dysfunction Signs in Doxorubicin Chemotherapy in Patients with Breast Cancer of Moderate and Low HFA-ICOS Risk Groups. «FIRMA «SILICEA» LLC.